摩通:维持三大航增持评级,偏好南方航空(1055.HK)
摩根大通发表研究报告指,中国航空公司即将发布首季业绩,料受最近的疫情重现影响,表现将较疲弱。该行维持中国国航(0753.HK)、中国南方航空(1055.HK)及中国东方航空(0670.HK)增持评级,目标价分别为8.2港元、6.7港元及4.4港元,较偏好南方航空及春秋航空。
该行建议在业绩公布前后逢低买入,认为第二季将因本地航线复苏而出现强劲反弹,以及国际战线重新部署的运力有所增加。该行续指,清明节假期国内客流量完全反弹至2019年同期水平,表现强劲,预计国内运量增长将进一步回升,与2019年同期相比可能出现双位数的增长。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.